World Diabetes Day 2024: Let’s talk about well-being for a better life with diabetes

The diagnosis of diabetes mellitus is a major life-changing event and an enormous burden for those affected. The development of the disease and the risk of subsequent diseases are substantially influenced not only by physical but also by psychological factors.

Compared to the general population, people with diabetes show a two to three times higher risk of developing depression. Furthermore, the risk of cognitive deficits such as dementia is significantly higher. As a result of the serious secondary diseases, the quality of life of patients with diabetes is severely reduced and life expectancy is shortened.

Maintaining quality of life and preventing secondary diseases by normalizing blood glucose levels are important therapeutic goals. The combination of modern diagnostic and treatment options and an enhanced understanding of the disease makes it possible to achieve these goals. In this context, monitoring of the glycemic status is an important pillar of diabetes diagnostics.

As a manufacturer with many years of experience in the field of clinical chemistry and immunoturbidimetric reagents, DiaSys makes a valuable contribution to the diagnosis and monitoring of diabetes. Furthermore, DiaSys offers systems for near patient diagnostics.